Product liability in respect of drugs.

نویسندگان

  • A L Diamond
  • D R Laurence
چکیده

Two professors, one of law and the other of pharmacology, trace the development of English law on compensation for injuries caused by defective drugs and examine the Vaccine Damage Payments Act of 1980, which established a no-fault system of compensation for vaccine injuries for a limited number of diseases. They discuss two possible approaches to handling compensation for drug-induced injuries in the future--use of the law of "strict liability" or creation of a no-fault system. The authors propose a model no-fault scheme and urge that the principal interested parties develop such a no-fault system without waiting for government action.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

تحلیل انتقادی قانون تعیین حدود مسئولیت شرکت‏های هواپیمایی ایرانی مصوب 11/5/1391

  Liability of air carriers especially in respect of liability limits has been subject of various regulations in both domestic and international levels. Our country by ratifying 1929 Warsaw convention and subsequent protocols in 1976 has regulated liability limits of Iranian airlines in various milestones including 1980, 1982 and 1984 and finally passed the Act of Delimiting Liability of Iran...

متن کامل

Corporate risk management: evidence from product liability

In this paper we examine the factors that determine how firms manage large, firmspecific risks, in this case, product liability. The risk of being sued for defective products or damage from defective products poses a small probability of a great loss to the firm. Product liability exposure arises from the firm’s choice of products and markets; choices that are fundamental to the firm’s business...

متن کامل

Cumulative Harm and Resilient Liability Rules for Product Markets*

In the traditional model of the law and economics of torts, harm accrues proportional to use. This has the remarkable implication for products-generated torts that product performance concerns (e.g., issues of care and of liability for harm) can be considered independently of market performance concerns (e.g., market structure and competition). Moreover, the classical analysis finds that all li...

متن کامل

Descriptive Study on "Market Share Liability" in Iranian Rules of Jurisprudence

The release of some estrogenic drugs in the sixties which produced with several therapeutic goals mostly prevention of abortion followed in similar cancer for the children born from the users. However, such cancers identified as the subsequent use of the drugs, due to a multiplicity of pharmacists and the inability of patients to identify the leading manufacturers, the law cases failed to prove...

متن کامل

Nber Working Paper Series the Effects of Product Liability Exemption in the Presence of the Fda

In the United States, drugs are jointly regulated by the US Food and Drug Administration, which oversees premarket clinical trials designed to ensure drug safety and efficacy, and the liability system, which allows patients to sue manufacturers for unsafe drugs. In this paper, we examine the potential welfare effects of this dual system to ensure the safety of medical products, and conclude tha...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • British medical journal

دوره 290 6465  شماره 

صفحات  -

تاریخ انتشار 1985